SpineThera is a clinical stage pharmaceutical company working to improve the lives of patients by creating injectable drugs utilizing its proprietary and differentiated sustained-release micro-suspension platform technology. Our goal is to develop proprietary drugs that offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. The company's lead investigational drug product, SX600, is a novel formulation of dexamethasone being developed for lumbar radiculopathy. SpineThera, Inc., is based is Medical Alley, Minnesota, the global epicenter of health innovation and care. SpineThera Australia Pty Ltd is a wholly owned subsidiary of SpineThera, Inc., and is the sponsor of the SALIENT study.
| Website | http://www.spinethera.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 15600 Medina Rd Ste 247, Plymouth, Minnesota 55447, US |
| Phone | +1 612-444-1154 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Medtronic, DePuy Synthes, Stryker, Globus Medical, Orthofix, Exactech, Spinal Resources, K2M, OrthoLite, Impulse Monitoring +28 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular SpineThera Inc employee's phone or email?
SpineThera Inc Questions
The SpineThera Inc annual revenue was $1 million in 2026.
SpineThera Inc is based in Plymouth, Minnesota.
The NAICS codes for SpineThera Inc are [32541, 3254, 325, 32].
The SIC codes for SpineThera Inc are [283, 28].
